Skip to main content

Table 1 Characteristics of the 108 patients with non-small-cell lung cancer enrolled in the study

From: Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy

 

Patients

 

N

%

Age, Years

  

   Median

63

   Range

29 - 77

Gender

  

   Male

66

61.1

   Female

42

38.9

Stage

  

   IIIA

6

5.5

   IIIB

30

27.8

   IV

72

66.7

PS

  

   0

23

21.3

   1

85

78.7

Chemotherapy regimen

  

   CBDCA+PAC

89

82.4

   CBDCA+GEM

17

15.7

   CDDP+GEM

2

1.9

Definitive thoracic radiotherapy

  

   Yes

20

18.5

   No

88

81.5

  1. Abbreviations: CBDCA, carboplatin; PAC, paclitaxel; CDDP, cisplatin; GEM, gemcitabine